Bristol-Myers Buy Medarex For $2.4B - Bloomberg
444 views · Published 23 July 2009 · 0:26 · Indexed 20 September 2026
Channel: Bloomberg Originals · 2009 · News & Politics
Bristol-Myers buys Medarex for $2.4 billion to gain ownership of a skin cancer drug that is nearing F.D.A approval. (Bloomberg News)
More from this channel
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg
-
1:01
Broadway At Tony Awards - Bloomberg